Alopecia areata after dupilumab for atopic dermatitis
Author:
Publisher
Elsevier BV
Subject
Dermatology
Reference5 articles.
1. IL-4Ralpha inhibitor for atopic disease;Chang;Cell,2017
2. Dupilumab: first global approval;Shirley;Drugs,2017
3. Three months of rifapentine and isoniazid for latent tuberculosis infection;Sterling;N Engl J Med,2011
4. The changing landscape of alopecia areata: the therapeutic paradigm;Revert-Yuval;Adv Ther,2017
5. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis;Werfel;J Allergy Clin Immunol,2016
Cited by 60 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children;Frontiers in Immunology;2024-06-06
2. In Response to Real‐World Adverse Events After Type 2 Biologic use in Chronic Rhinosinusitis with Nasal Polyps;The Laryngoscope;2024-06-04
3. Long-term, observational, real-world study of dupilumab for the treatment of moderate-to-severe atopic dermatitis: a 52-week single-center retrospective analysis in China;Archives of Dermatological Research;2024-05-31
4. Dupliumab therapy for alopecia areata: a case series and review of the literature;Journal of Dermatological Treatment;2024-02-11
5. Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib;Frontiers in Medicine;2023-10-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3